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Hypoxia has been repeatedly demonstrated to have an adverse prognostic impact in various 
types of tumors [1]. A growing body of evidence indicates its central role in both, malignant 
progression, as well as in resistance to cancer treatment. While diminishing the efficiency of 
some forms of therapy, hypoxia also provides an opportunity for a new class of drugs, so called 
bioreductive drugs, specifically engineered to require hypoxic conditions for activation [2]. The 
development and in-vitro evaluation of these compounds however requires precise control over 
the cellular micro-environment, something not easily accomplished with traditional well-based 
cell-culture assays performed in air (~21% O2).  
However, the use of microfluidics, a new fast-growing area of research and development, 
promises to overcome the limitations of open culture systems by relocating cells and reactions 
into enclosed microchannels on Lab-on-a-Chip devices. Recently we have introduced a novel 
optical oxygen sensor capable of resolving biologically relevant oxygen levels in such devices via 
fluorescence microscopy [3]. When combined with microfluidic flow control, cells cultured inside a 
parallel-plate microchamber could be exposed to custom transverse oxygen gradients with 
intermediate levels ranging between hypoxic (0 mg/L O2) to hyperoxic (34 mg/L O2, saturation) 
conditions [4].  
In this paper we will demonstrate spatially-resolved visualization of oxygen dissolved in a liquid 
medium and introduce two microfluidic devices for cell-culture experiments with integrated 
oxygen control. We will further show how these devices can be used to retain clusters or even 
individual cells within larger populations under hypoxic conditions, a capability which will allow the 
evaluation of cancer drugs on a cell-to-cell basis. In general, the combination of the oxygen 
sensor system with microfluidic culture devices has the potential to significantly improve the 
relevance of current cancer drug assays.    
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